Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
Clinical trial NCT01730040 · COMPLETED
Trial details
- NCT number
- NCT01730040
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.